Impact of hormone receptor status and tumor subtypes on clinical behavior and outcomes of breast cancer in young BRCA carriers.
Year: 2024
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Luca Arecco, Marco Bruzzone, Anne-Sophie Hamy, Hee Jeong Kim, Antonio Di Meglio, Rinat Bernstein-Molho, Florentine Hilbers, Katarzyna Pogoda, Estela Carrasco, Kevin Punie, Jyoti Bajpai, Elisa Agostinetto, Nerea Lopetegui-Lia, Ann H. Partridge, Kelly-Anne Phillips, Angela Toss, Christine Rousset-Jablonski, Giuseppe Curigliano, Eva Blondeaux, Matteo Lambertini
Institutions: Institut Jules Bordet, University of Genoa, Ospedale Policlinico San Martino, Université Paris Cité, Institut Curie, Asan Medical Center, University of Ulsan, Inserm, Institut Gustave Roussy, Fondation Gustave Roussy, Sheba Medical Center, The Netherlands Cancer Institute, The Maria Sklodowska-Curie National Research Institute of Oncology, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology, KU Leuven, Tata Memorial Hospital, Université Libre de Bruxelles, Cleveland Clinic, Dana-Farber Cancer Institute, The University of Melbourne, Peter MacCallum Cancer Centre, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Lyon 1 Université, Centre Léon Bérard, Research on healthcare performance, University of Milan, European Institute of Oncology
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4399121939